The frequency of CD4 + CD25 + FoxP3 + CD127 − cells in Bet v 1 contiguous overlapping peptide immunotherapy as a putative marker of efficacy

Allergy ◽  
2020 ◽  
Vol 75 (10) ◽  
pp. 2685-2686 ◽  
Author(s):  
Paweł Gajdanowicz ◽  
Dries Van Elst ◽  
Sylwia Smolińska ◽  
Andrzej Eljaszewicz ◽  
Liam O'Mahony ◽  
...  
Keyword(s):  
Peptide Immunotherapy ◽  
Bet V 1 ◽  
Putative Marker

scholarly journals Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season

2018 ◽  
Vol 142 (2) ◽  
pp. 678-680.e7 ◽  
Author(s):  
Alexander Kettner ◽  
Gilles DellaCorte ◽  
Fréderic de Blay ◽  
Lars Jacobsen ◽  
Marek Jutel ◽  
...  
Keyword(s):  
Peptide Immunotherapy ◽  
Bet V 1

Quantification in mass units of Bet v 1, the main allergen of Betula verrucosa pollen, by a monoclonal antibody based-ELISA

1997 ◽  
Vol 27 (8) ◽  
pp. 926-931 ◽  
Author(s):  
J. RAMiREZ ◽  
J. A. CARPIZO ◽  
H. IPSEN ◽  
J. CARREIRA ◽  
M. LOMBARDERO
Keyword(s):  
Monoclonal Antibody ◽  
Bet V 1 ◽  
Betula Verrucosa

scholarly journals Bet v 1 from birch pollen is a hypoallergen with vitamin D3 in the pocket

Allergy ◽  
2021 ◽  
Author(s):  
Karin Hufnagl ◽  
Livia Kromp ◽  
Rodolfo Bianchini ◽  
Sheriene Moussa Afify ◽  
Markus Wiederstein ◽  
...  
Keyword(s):  
Vitamin D3 ◽  
Birch Pollen ◽  
Bet V 1

Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model

Allergy ◽  
2013 ◽  
Vol 69 (3) ◽  
pp. 328-337 ◽  
Author(s):  
S. Siebeneicher ◽  
S. Reuter ◽  
M. Krause ◽  
A. Wangorsch ◽  
J. Maxeiner ◽  
...  
Keyword(s):  
Allergic Asthma ◽  
Murine Model ◽  
Immune Modulation ◽  
Bet V 1
Sign in / Sign up

Export Citation Format

Share Document